STOCK TITAN

Janel SEC Filings

JANL OTC

Welcome to our dedicated page for Janel SEC filings (Ticker: JANL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Janel's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Janel's regulatory disclosures and financial reporting.

Rhea-AI Summary

Gerard van Kesteren, a director of JANEL CORP (JANL), reported a transaction dated 10/01/2025 on SEC Form 4. The filing shows an acquisition (Code A) of 2,500 derivative securities in the form of stock options with a conversion/exercise price of $36.01. The options list a date exercisable of 12/31/2028 and an expiration date of 09/30/2035. Following the reported transaction, the reporting person beneficially owns 2,500 of the derivative securities as a direct owner. The form is signed by Gerard van Kesteren on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Karen Miller Ryan, a director of JANEL CORP (JANL), reported a transaction dated 10/01/2025 involving 2,500 derivative securities described as a Stock Option (Right to Buy) with an exercise price of $36.01. The Form 4 shows the transaction code A (acquisition) for 2,500 underlying shares of Common Stock, and reports 2,500 shares beneficially owned following the reported transaction, held directly. The Form lists a Date Exercisable of 12/31/2028 and an Expiration Date of 09/30/2035.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

John J. Gonzalez II, a director of JANEL CORP (JANL), reported a transaction on Form 4 showing he exercised stock options on 10/01/2025. The exercise purchased 2,500 shares of common stock underlying a stock option with an exercise price of $36.01. After the transaction Mr. Gonzalez directly beneficially owns 2,500 shares.

The option's terms show it was exercisable on 12/31/2028 with an expiration date of 09/30/2035, and the reported filing date and signature are 10/03/2025. The Form 4 identifies the filing as by one reporting person and lists Mr. Gonzalez's address in New York, NY.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Gregory J. Melsen, a director of JANEL CORP (ticker JANL), reported an acquisition on 10/01/2025 of a stock option giving the right to buy 2,500 shares of common stock at a conversion/exercise price of $36.01. The option becomes exercisable on 12/31/2028 and expires on 09/30/2035. Following the reported transaction, Mr. Melsen directly beneficially owns 2,500 shares/options as disclosed on the Form 4.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Janel Corp director Gregory B. Graves reported a non-cash acquisition on 10/01/2025 of a stock option covering 2,500 shares with an exercise price of $36.01. The option becomes exercisable on 12/31/2028 and expires on 09/30/2035. Following the reported transaction the filing lists 2,500 shares/units beneficially owned by Mr. Graves directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Janel

OTC:JANL

JANL Rankings

JANL Stock Data

212.99k